Genitourinary Pathology/Kidney Cancer/Prostate Cancer/Urothelial Carcinoma
Cytopathology/Thyroid Cytopathology
MD Anderson Cancer Center
Houston, TX
Fellowship - Cytopathology
2009
MD Anderson Cancer Center
Houston, TX
Fellowship - Genotourinary Pathology
2008
Loyola University
Maywood, IL
Residency - AP/CP Pathology
2007
University of Belgrade Medical School
Belgrade, Serbia
MD - Medicine
1991
PAX8-positive conventional urothelial carcinomas of the urinary bladder and their distinct molecular profiles - A clinicopathologic study of 101 consecutive cases with next-generation sequencing in 20 cases.
PAX8-positive conventional urothelial carcinomas of the urinary bladder and their distinct molecular profiles - A clinicopathologic study of 101 consecutive cases with next-generation sequencing in 20 cases. Histopathology. 2026 Feb 06.
PMID: 41652309
Percutaneous renal mass biopsies with no viable lesional cells - Recognizing different histologic patterns can help predict nondiagnostic vs. true negative biopsy and guide clinical management.
Percutaneous renal mass biopsies with no viable lesional cells - Recognizing different histologic patterns can help predict nondiagnostic vs. true negative biopsy and guide clinical management. Ann Diagn Pathol. 2026 Jun; 82:152607.
PMID: 41520489
Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features.
Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features. Histopathology. 2026 Apr; 88(5):1044-1050.
PMID: 41400361
MTOR-mutated eosinophilic renal cell carcinomas with loss of chromosome 1 and high metastatic potential: further expanding the spectrum of TSC/mTOR pathway mutated renal tumors.
MTOR-mutated eosinophilic renal cell carcinomas with loss of chromosome 1 and high metastatic potential: further expanding the spectrum of TSC/mTOR pathway mutated renal tumors. Virchows Arch. 2025 Nov 27.
PMID: 41299159
Gender Inclusion in the Cytopathology Laboratory: Review of Current Practice and Call to Action.
Gender Inclusion in the Cytopathology Laboratory: Review of Current Practice and Call to Action. Arch Pathol Lab Med. 2025 Aug 20; 150(2):122-128.
PMID: 40833050
Renal Tumorigenesis via RAS/RAF/MAPK Pathway Alterations Beyond Papillary Renal Neoplasm With Reverse Polarity.
Renal Tumorigenesis via RAS/RAF/MAPK Pathway Alterations Beyond Papillary Renal Neoplasm With Reverse Polarity. Am J Surg Pathol. 2025 Dec 01; 49(12):1266-1278.
PMID: 40557814
Primary Melanoma of the Lung: A Vanishing Entity.
Primary Melanoma of the Lung: A Vanishing Entity. Acta Cytol. 2025; 69(4):361-366.
PMID: 40373758
Prospective Validation of an Automated Hybrid Multidimensional MRI Tool for Prostate Cancer Detection Using Targeted Biopsy: Comparison with PI-RADS-based Assessment.
Prospective Validation of an Automated Hybrid Multidimensional MRI Tool for Prostate Cancer Detection Using Targeted Biopsy: Comparison with PI-RADS-based Assessment. Radiol Imaging Cancer. 2025 Jan; 7(1):e240156.
PMID: 39836080
Aggressive renal cell carcinoma with somatic BRCA2 mutation-an emerging entity? A case report with literature review.
Aggressive renal cell carcinoma with somatic BRCA2 mutation-an emerging entity? A case report with literature review. Virchows Arch. 2025 Aug; 487(2):471-476.
PMID: 39673614
Organ-confined prostate cancer with negative surgical margins in an entirely-embedded radical prostatectomy is essentially non-lethal-a retrospective single-institutional study of 520 patients.
Organ-confined prostate cancer with negative surgical margins in an entirely-embedded radical prostatectomy is essentially non-lethal-a retrospective single-institutional study of 520 patients. Int Urol Nephrol. 2025 Apr; 57(4):1105-1112.
PMID: 39576420